To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers

NCT07719946 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Haploidentical Hematopoietic Stem Cell Transplant
Hematological Malignancies

Interventions

DRUG: Cyclophosphamide

Sponsor

Tata Memorial Centre

Collaborators

[object Object]